VANCOUVER, BC, March 24, 2021
/CNW/ - Zenabis Global
Inc. (TSX: ZENA) ("Zenabis"
or the "Company") announces the launch of pre-roll
multipacks as well as new distribution agreements.
Zenabis' continues to expand on the popularity of its
value-oriented Re-Up portfolio with the launch of its new 10 and
20, Multi-Pack Indica and Sativa
0.5g Pre-Roll formats. This unique, multi-pack will be available
initally in Quebec and
Alberta in the larger, 20-pack
format in early April with national rollout of both formats
expected to be in time for the 4/20 celebrations. The full impact
of the launch is expected to be reflected in Zenabis's Q2 2021
results.
Zenabis' multipack pre-roll offering will serve consumers
seeking better value for money and larger package sizes to reduce
the frequency of purchases. These new products build on the success
of Zenabis popular 28g Re-Up Indica / Sativa products. The launch
of the 10 / 20 Multi-Pack
Pre-Roll format underpins Zenabis strategy of leveraging its
ability to deliver the quality and affordability expected by its
loyal customer base while delivering on the top and bottom line
performance anticipated by shareholders.
Zenabis is also excited to announce that it has concluded
agreements with Cannabis NL (Newfoundland and Labrador) and the government of Nunavut, completing its goal of extending the
availability of its Namaste and Re-Up products to all Canadian
provinces and territories. Shipments under these new agreements
commence in April. Zenabis joins a small, select group of
Canadian LPs whose product quality and value have been recognized
as a must-have, on-shelf product by every Provincial &
Territorial Board in Canada. These
new agreements further cement Zenabis as one of the top
recreational LP's in the country.
"Finalizing agreements with Cannabis NL and the government of
Nunavut, which means making good
on our promise of making our Namaste and Re-Up brands available
from coast-to-coast-to-coast, is a benchmark moment for this
organization. We continue to portray what a lean, nimble company
that grows really, really good cannabis can achieve. The
addition of the pre-roll multipack to our assortment builds on
Re-Up's brand purpose of providing affordable, high-THC products to
our value-oriented customers" stated Robert Maxwell, Zenabis'
Vice President, Sales and Marketing..
About
Zenabis is a
leading Canadian licensed cultivator of cannabis
for medical and recreational use. Zenabis employs
staff coast-to-coast, with three licenced Canadian
facilities in Atholville, New Brunswick; Langley, British Columbia; and Stellarton,
Nova Scotia. Zenabis serves international markets
directly and in partnership with
its joint venture, ZenPharm operating
from Birżebbuġa, Malta. Zenabis distributes
cannabis products and derivatives under the Zenabis, Namaste and
Re-Up brand names.
Forward Looking Information
This news release
contains statements that may constitute
"forward-looking information" within the meaning of
applicable Canadian securities legislation. Forward-looking
information may include, among others, statements regarding the
future plans, costs, objectives or performance of Zenabis, or the
assumptions underlying any of the foregoing. In this news release,
words such as "may", "would", "could", "will", "likely", "believe",
"expect", "anticipate", "intend", "plan", "estimate" and similar
words and the negative form thereof are used to identify
forward-looking statements. In this news release, forward-looking
statements relate, among other things, to: this unique, multi-pack
will be available initally in Quebec and Alberta in the larger, 20-pack format in early
April with national rollout of both formats expected to be in time
for the 4/20 celebrations; the full impact of the launch is
expected to be reflected in Zenabis's Q2 2021 results; Zenabis'
multipack pre-roll offering will serve consumers seeking better
value for money and larger package sizes to reduce the frequency of
purchases; and, shipments under these new agreements commence in
April. These risks, uncertainties and assumptions include, but are
not limited to, those described in the shelf prospectus dated
April 9, 2019 as supplemented by a
prospectus supplement dated September 18,
2020 and the annual information form dated
March 30, 2020, copies of which are
available on SEDAR at www.sedar.com and could cause actual events
or results to differ materially from those projected in any
forward-looking statements. Furthermore, any forward-looking
information with respect to available space for cannabis production
is subject to the qualification that management of Zenabis may
decide not to use all available space for cannabis production, and
the assumptions that any construction or conversion would not be
cost prohibitive, required permits will be obtained and the labour,
materials and equipment necessary to complete such construction or
conversion will be available. Forward-looking statements or
information involve known and unknown risks, uncertainties and
other factors which may cause the actual results, performance or
achievements of the Company to be materially different from any
future results, performance or achievements expressed or implied by
the forward-looking statements or information contained in this
news release. Accordingly, readers should not place undue reliance
on the forward-looking statements and information contained in this
news release. Zenabis does not intend, nor undertake any
obligation, to update or revise any forward-looking information
contained in this news release to reflect subsequent information,
events or circumstances or otherwise, except if required by
applicable laws.
For more information, visit: https://www.zenabis.com.
SOURCE Zenabis Global Inc.